Leveraging Cytokines to Enhance the Efficacy of CAR-T Cell Therapy
Chimeric antigen receptor (CAR) T-cell therapy represents a revolutionary advancement in cancer treatment. Utilizing CAR technology, T-cells are engineered to recognize and attack specific tumor cells, overcoming limitations of the traditional immune system. CARs bind to specific antigens
